Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

RegMed Daily, Closing Bell, 11/17/11, backlash to universe concurrent with market dive

End of Day, Cause and Effect …

 

Many of the RegMed companies are feeling the … backlash … unfairly (what is fair in this market … as perception becomes reality … but, for how long!) from Monday’s announcement from Geron (NASDAQ:GERN) which has affected the perception of the stem cell universe …

Forward and far-sighted investors will profit (if, their pockets are not already been emptied) from these … lows …  however, managements … must be aware on the new realities … and communicate more effectively!!

Closing Bell: The NASDAQ closed DOWN -51.62 (-1.96%) to 2,587.99. The Dow closed DOWN -134.86 (-1.13%) to 11,770.73.

Who’s up … at the close and any … whys:  Dendreon (NASDAQ:DNDN) +$0.60 <+7.99%. to $8.11; International Ste Cell (OTC BB: ISCO) +$0.01 <1.67%> to $0.61: Neuralstem (Amex: CUR) +$0.02 <+1.79%> to $1.14; ImmunoCellular (OTC BB: IMUC) +$0.02 <+1.43%> to $1.42 and ReNeuron (RENE.LON) +$1.38 <+28.77%> to $6.18. 

**<Small/Moderate Volumes>